Mass General Hospital -MGH

Boston, Massachusetts 02114

2 studies enrolling now · 3 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Carcinoma, Transitional Cell, Coronary Artery Disease, Transitional Cell Carcinoma of Renal Pelvis, Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter, Urothelial Carcinoma Ureter Recurrent, Urothelial Carcinoma of the Renal Pelvis and Ureter

Studies at this site

• A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS) — Recruiting now
• uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto — Recruiting now
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. — Completed